Influenza: global surveillance for epidemic and pandemic variants.
Influenza viruses, unlike other viruses for which vaccines have been developed, undergo rapid and unpredictable antigenic variation in the hemagglutinin (HA), the surface glycoprotein primarily responsible for eliciting neutralizing antibodies during infection. Because of this antigenic variability and its consequences, the World Health Organization (WHO) in 1947 established an international network of collaborating laboratories to monitor the emergence and spread of new epidemic and pandemic strains of influenza. This network now includes three international WHO collaborating centers and over 100 WHO national collaborating laboratories. The primary purpose of this network is to detect, through laboratory surveillance, the emergence and spread of antigenic variants of influenza that may signal a need to update the formulation of the influenza vaccine. This laboratory surveillance network has provided the strains needed to update the vaccine as well as a repository of influenza viruses useful for studying the antigenic and genetic evolution of this virus. Knowledge gained from molecular studies on the evolution of drift variants and on the emergence of pandemic strains has made influenza a useful model for understanding the potential threat of other emerging or reemerging microbial diseases.
Cox
N J
NJ
WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, Georgia.
Brammer
T L
TL
Regnery
H L
HL
D000940:Antigenic Variation / Q000235:genetics; D001208:Asia / Q000453:epidemiology; D002681:China / Q000453:epidemiology; D004196:Disease Outbreaks; D005814:Genes, Viral / Q000235:genetics; D006389:Hemagglutinins, Viral / Q000235:genetics / Q000276:immunology; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology; D007255:Information Services; D009975:Orthomyxoviridae / Q000145:classification / Q000235:genetics / Q000276:immunology; D011159:Population Surveillance; D014944:World Health Organization
D006389:Hemagglutinins, Viral; D007252:Influenza Vaccines